Navigation Links
Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit
Date:11/19/2008

MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (AMEX: SYI) today announced that it has submitted, and that the FDA has received its application for 510(k) clearance for its HAPTOCHEK(TM) diagnostic test kit. The 510(k) submission begins a 90-day review process, during which the FDA will determine whether the kit can be distributed to labs throughout the country as an in vitro diagnostic.

"We are very pleased to announce the submission of a 510(k) application for our test kit to the FDA, as it demonstrates that we are continuing to execute on our business plan," said Noah Berkowitz, M.D., President and CEO of Synvista Therapeutics. "We believe that, once cleared by the FDA, our test will become an important facilitator of personalized medicine and may provide a standard by which physicians can influence clinical outcome."

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing clinical diagnostic laboratory tests and drugs to diagnose, treat and prevent cardiovascular disease in people with diabetes. The Company has developed a protein-based clinical laboratory test to identify patients with Hp2-2 diabetes. Tests which identify patients with Hp2-2 diabetes may be useful in identifying diabetic patients at high risk for cardiovascular complications. These patients may benefit from a particular formulation of vitamin E. The Company is also developing a kit to measure CML (carboxy-methyllysine), another potential cardiovascular risk marker.

Synvista Therapeutics is developing oral antioxidant drugs to treat the HDL dysfunction seen in Hp2-2 diabetes, a disease affecting almost 7 million patients in the United States. The Company is also developing alagebrium, a proposed breaker of advanced glycation endprodu
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Synvista Therapeutics to Present at the BIO InvestorForum 2007
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
4. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
7. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
9. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
10. Synvista Therapeutics Posts Letter to Stockholders on Web Site
11. Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... Report" report to their offering. This ... (SOFCs) in US$ Thousands. The report provides separate comprehensive analytics ... Europe , Asia-Pacific , and Rest ... period 2012 through 2020. Market data and analytics are derived ...
(Date:8/19/2014)... 19, 2014 In November 2012, the European ... Evaluation Report (PBRER) in a new PSUR – responding to ... benefit-risk profile of a drug. Adopted in many regions, the ... Present a comprehensive and critical analysis of new or ... Highlight any new evidence of the potential benefits of ...
(Date:8/18/2014)... A new therapy developed by researchers at the ... Medicine and Columbia University Medical Center (CUMC) may ... disease treatment. , The researchers demonstrated in ... could selectively inhibit blood vessel re-narrowing and simultaneously ... a balloon catheter to open narrowed or blocked ...
(Date:8/18/2014)... Global HIV Infection Drug Market and Pipeline Insight ... of HIV infection and the number of deaths due to ... rate across the globe. It has been estimated that the ... in 2013, with the rates for children being even much ... infection rates has been the improved access to antiretroviral drugs ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4
... (Nasdaq: DCGN ) today report the discovery of ... genome (SNPs) that,regulate one of the principle motors of ... have a genome-wide impact on the rate of,recombination -- ... formation,of eggs and sperm. Recombination is largely responsible for ...
... leading global,full-service contract research organization, announced it has ... Pharmacology., Dr. Wei joins Medpace with extensive ... phase cardio-metabolic studies. He will consult,with sponsors on ... which studies merit inclusion in the programs and ...
... -- Max Nutrition Inc.,(OTC Bulletin Board: MXNU; the ... share exchange (the "Closing") pursuant to an Agreement,and ... a,Delaware corporation ("ASPI"). Pursuant to the Agreement, ASPI ... Gansu Biology Science and,Technology Stock Co., Ltd ("GDBS") ...
Cached Biology Technology:deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women 2deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women 3deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women 4Medpace Hires Clinical Pharmacologist, Jim Wei, MD, PhD 2Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc. 2
(Date:8/19/2014)... rating systems be used in supermarkets to encourage healthier ... sought to answer that very question by tracking the ... Guiding Stars System to rate the nutritional value of ... and Brand Lab,s David Just, PhD, and Brian Wansink ... sales records of over 150 Hannaford Supermarkets in the ...
(Date:8/19/2014)... lemur. It,s not an African Bush Baby or even a ... downright "cool" primate from Southeast Asia. , "It,s really not ... Brown, curator-in-charge at the University of Kansas, Biodiversity Institute. "A ... body; a long tail with a furry tuft at the ... a bit like the disks on the digits of tree ...
(Date:8/19/2014)... devised a new implantable tissue scaffold coated with bone ... weeks. When applied to bone injuries or defects, this ... bone that looks and behaves just like the original ... a dramatic improvement over the current standard for treating ... of the patient,s body a painful process that ...
Breaking Biology News(10 mins):Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Engineering new bone growth 2Engineering new bone growth 3
... at UC San Diego have developed a method that ... attach chemical probes onto proteins and subsequently remove them ... paper that appears online this week in the journal ... understand the biochemistry of naturally formed proteins in order ...
... to develop technologies to dramatically reduce the cost ... Institute (NHGRI), part of the National Institutes of ... DNA sequencing costs have fallen dramatically (see www.genome.gov/sequencingcosts), ... by genomics researchers. In 2004, NHGRI launched the ...
... Using ultrasound waves, MIT engineers have found a way ... transdermal drug delivery more efficient. This technology could pave ... according to the researchers. "This could be used ... example systemic drugs and proteins such as insulin, ...
Cached Biology News:Chemists develop reversible method of tagging proteins 2Chemists develop reversible method of tagging proteins 3New NIH/NHGRI grants to harness nanoscale technologies to cut DNA sequencing costs 2New NIH/NHGRI grants to harness nanoscale technologies to cut DNA sequencing costs 3Getting (drugs) under your skin 2Getting (drugs) under your skin 3
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
... Polystyrene covers can be ... Ridged covers for stacking ... Non-ridged covers for use with ... covers, ridged and non-ridged, are ...
... can be used with all ... for stacking of covered plates ... use with automated systems ... non-ridged, are available for use ...
... made from an inert polymer with a unique ... 384 split septum caps for use with 384-well ... PCR when used in conjunction with screw or ... standard pipetting equipment 384 septum caps may ...
Biology Products: